Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unibar is a private Houston-based plant-derived life science company focused on branded nutraceutical and cosmeceutical ingredients rather than prescription therapeutics. The company develops science-backed botanical ingredients for eye health, active nutrition, weight management, skin health, immune health, and fortified nutrition, and commercializes products such as CapsiClear, UniGold, EktibaFlex, CurQnetic, Bellaneo, and Univita. Its model combines Ayurvedic botanical knowledge with modern formulation, analytical testing, clinical and preclinical validation, and partnerships with large-scale manufacturers in India. Unibar appears to operate as a commercial ingredient supplier with proprietary formulations, patents, and quality systems rather than as a clinical-stage drug developer. Its most differentiated franchise is in eye health, where CapsiClear has been positioned as a clinically studied capsanthin ingredient for ocular wellness and intraocular pressure support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unibar.